NCT03366974View on ClinicalTrials.gov

Assessment of Change in CYP3A Activity by Route of Administration Using Metabolic Markers in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

December 28, 2017

Primary Completion Date

February 13, 2018

Study Completion Date

December 12, 2018

Conditions
Healthy Volunteers
Interventions
DRUG

Midazolam

Midazolam 5 mg PO, Midazolam 1 mg IV

DRUG

Clarithromycin

Clarithromycin 500 mg bid

DIETARY_SUPPLEMENT

Grapefruit juice

Grapefruit juice 500 mL

Trial Locations (1)

Unknown

Seoul National University Hospital, Seoul

All Listed Sponsors
lead

Seoul National University Hospital

OTHER

NCT03366974 - Assessment of Change in CYP3A Activity by Route of Administration Using Metabolic Markers in Healthy Male Volunteers | Biotech Hunter | Biotech Hunter